Absence of alsin function leads to corticospinal motor neuron vulnerability via novel disease mechanisms
Human Molecular Genetics, 2016, Vol. 25, No. 6
1074–1087
doi: 10.1093/hmg/ddv631
Advance Access Publication Date: 10 January 2016
Original Article
ORIGINAL ARTICLE
Absence of alsin function leads to corticospinal motor
neuron vulnerability via novel disease mechanisms
1
Department of Neurology and, 2Department of Physiology, Feinberg School of Medicine, Northwestern
University, Chicago, IL, USA, 3Robert H. Lurie Comprehensive Cancer Center and 4Cognitive Neurology and
Alzheimer’s Disease Center, Northwestern University, Chicago, IL 60611, USA
*To whom correspondence should be addressed. Tel: +312 503 2774; Email:
Abstract
Mutations in the ALS2 gene result in early-onset amyotrophic lateral sclerosis, infantile-onset ascending hereditary spastic
paraplegia and juvenile primary lateral sclerosis, suggesting prominent upper motor neuron involvement. However, the
importance of alsin function for corticospinal motor neuron (CSMN) health and stability remains unknown. To date, four separate
alsin knockout (AlsinKO) mouse models have been generated, and despite hopes of mimicking human pathology, none displayed
profound motor function defects. This, however, does not rule out the possibility of neuronal defects within CSMN, which is not
easy to detect in these mice. Detailed cellular analysis of CSMN has been hampered due to their limited numbers and the complex
and heterogeneous structure of the cerebral cortex. In an effort to visualize CSMN in vivo and to investigate precise aspects of
neuronal abnormalities in the absence of alsin function, we generated AlsinKO-UeGFP mice, by crossing AlsinKO and UCHL1-eGFP
mice, a CSMN reporter line. We find that CSMN display vacuolated apical dendrites with increased autophagy, shrinkage of soma
size and axonal pathology even in the pons region. Immunocytochemistry coupled with electron microscopy reveal that alsin is
important for maintaining cellular cytoarchitecture and integrity of cellular organelles. In its absence, CSMN displays selective
defects both in mitochondria and Golgi apparatus. UCHL1-eGFP mice help understand the underlying cellular factors that lead to
CSMN vulnerability in diseases, and our findings reveal unique importance of alsin function for CSMN health and stability.
Introduction
To date, numerous mutations have been identified to amyotrophic lateral sclerosis (ALS) and other related motor neuron
diseases. However, mutations in the Alsin2 (ALS2) gene are particularly important because, unlike other mutations, it mainly
affects young people. Mutations in this gene are detected
in juvenile cases of ALS, patients with juvenile primary lateral
sclerosis (PLS) (1), infantile-onset ascending hereditary spastic
paraplegia (IAHSP) (2) and are the most common cause of autosomal recessive juvenile ALS (1).
Alsin is a ubiquitous protein, expressed mainly in the central
nervous system, and is encoded by the ALS2 gene. ALS2 is located
on chromosome 2q33 contains 33 introns and 34 exons, and encodes two splice variant of alsin protein: a long form of 1657
amino acids and a short form of 396 amino acids (3). To date, 14 different mutations have been identified in the ALS2 gene in 24 ALS patients (4). In addition, a novel c.2761C > T mutation was found to
†
These authors contributed equally to this work.
Received: November 30, 2015. Revised: November 30, 2015. Accepted: December 29, 2015
© The Author 2016. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact
1074
Mukesh Gautam1, Javier H. Jara1,†, Gabriella Sekerkova2,†, Marina V. Yasvoina1,
Marco Martina2 and P. Hande Özdinler1,3,4, *
Human Molecular Genetics, 2016, Vol. 25, No. 6
line of AlsinKO, we reveal that apical dendrite degeneration is a
common cellular pathology for CSMN that become diseased for
different causes. In addition, we identify mitochondria and the
Golgi apparatus of CSMN as a target of cellular dysfunction in
the absence of alsin, thus revealing a novel importance of alsin
function for CSMN health and stability.
Results
Generation of a CSMN reporter line of AlsinKO mice
Because visualization and detailed cellular analysis of CSMN has
been a challenge in mouse models, we used UCHL1-eGFP mice as
a tool to generate reporter lines of motor neuron diseases in
which CSMN express eGFP that is stable even at postnatal day
(P) 800—2.5 years old—in vivo (20). AlsinKO mice, which lack alsin
function and display very minor motor neuron circuitry defects
by P300 have been generated and characterized (17). Here,
CSMN reporter line of AlsinKO mice, AlsinKO-UeGFP were generated
by two consecutive cross-breedings: AlsinHTmice were bred with
UCHL1-eGFP to get AlsinHT-UeGFP, which were crossed back to
AlsinHT mice to generate AlsinKO-UeGFP mice (Fig. 1A and B). All
mice resulting from these cross-breedings were viable and fertile,
without obvious developmental defects, and were born according to Mendelian ratios.
Neurons expressing eGFP (eGFP+) in AlsinWT-UeGFP and AlsinKOUeGFP mice were located in layer V of the motor cortex, displayed
pyramidal neuron morphology and a prominent apical dendrite
(Fig. 1C–E). In addition, eGFP+ neurons showed co-localization
with Ctip2 (subcerebral projection neuron marker (21), 95%; n = 246
neurons), but not with Satb2 (callosal projection neuron marker
(22), 5%; n = 192 neurons). eGFP+ neurons retained CSMN identity
in AlsinKO-UeGFP mice, even at P500 (Fig. 1F–I, arrows). CST axons,
labeled with eGFP, were detected in ventral pons as previously
documented in UCHL1-eGFP mice (20).
CST axons display the signs of degeneration
Silver staining revealed CST axon fiber degeneration in AlsinKO
mice, by P300 (17). To further investigate whether AlsinKO-UeGFP
mice recapitulate the CST axon pathology, we next studied the
health of the CST axons at the level of pons (Fig. 2A). Because
eGFP expression in CSMN allows visualization of single axon fibers
and overall health of the CST tract, details of axonal pathology
were revealed. The average fiber density was comparable between
AlsinWT-UeGFP: (120.7 ± 9/unit area) and AlsinKO-UeGFP: (99.6 ± 2.2/
unit area) at P300 (Fig. 2D), but there was a significant reduction
by P500 AlsinWT-UeGFP: (92.1 ± 9.9/unit area); AlsinKO-UeGFP:
(50.1 ± 6.8/unit area, P < 0.002) (Fig. 2D). The average axon fiber
cross-sectional area was reduced both at P300 (AlsinWT-UeGFP: 3.1
± 0.4 µm2, n = 31 axons; AlsinKO-UeGFP: 1.5 ± 0.2 µm2, n = 29 axons;
P < 0.03) and P500 (AlsinWT-UeGFP: 2.5 ± 0.1 µm2, n = 28 axons;
AlsinKO-UeGFP: 1.4 ± 0.1 µm2, n = 30 axons; P < 0.004; Fig. 2E).
GFP immunocytochemistry coupled with electron microscopic (EM) analysis further delineated the presence of many degenerating axon (...truncated)